News | 06.11.20
Thrombectomy for Stroke Studied in the Public Health Care System of Brazil
June 11, 2020—In a randomized trial conducted in the public health care system of Brazil, investigators concluded that endovascular treatment within 8 hours after the onset of stroke symptoms in conjunction with standard care resulted in better functional outcomes at 90 days than standard care alone.
News | 06.02.20
Large Study Compares Transradial and Transfemoral Approaches for Flow-Diverting Stent Placement
June 2, 2020—Transradial access (TRA) may be a safer approach than transfemoral access (TFA) for flow diversion procedures to treat cerebral aneurysms at a wide range of locations, concluded Yangchun Li, MD, et al in a study published online in Journal of NeuroInterventional Surgery (JNIS).
News | 05.29.20
SCAI Survey Finds That Americans Are Avoiding Treatment for Heart Attack and Stroke Because of COVID-19 Risk
May 29, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that findings from a newly released national survey confirm a growing concern among doctors and hospitals that people are more afraid of contracting COVID-19 by going to the hospital than seeking care for serious medical emergencies like heart attack or stroke.
News | 05.28.20
Study Confirms Stroke Patients Are Significantly Delaying Treatment During COVID-19 Pandemic
May 28, 2020—The Get Ahead of Stroke campaign from the Society of NeuroInterventional Surgery (SNIS) announced the publication of data showing ischemic stroke patients are arriving to hospitals and treatment centers an average of 160 minutes later during the COVID-19 pandemic, as compared with a similar timeframe in 2019.
News | 05.21.20
AHA Highlights Four Studies That Provide Global Snapshots of Stroke Treatment During COVID-19
May 21, 2020—The American Heart Association (AHA) announced the publication of four separate studies in Stroke that indicate that the rate of strokes in COVID-19 patients appears relatively low, but a higher proportion of those strokes are presenting in younger people and are often more severe compared with strokes in people who do not have the novel coronavirus.
News | 05.20.20
Relation of SARS2-CoV-2 and Stroke Evaluated in Patients in a New York Health Care System
May 20, 2020—NYU Langone Health in New York, New York, announced the publication of a study that showed fewer people than previously reported have had strokes as a result of COVID-19; however, strokes that accompany the pandemic virus, SARS-CoV-2, appear to be more severe.
News | 05.13.20
SNIS Issues Recommendation for Mechanical Thrombectomy and Care of Emergent Neurointerventional Patients in the COVID-19 Setting
May 13, 2020—The Society of NeuroInterventional Surgery (SNIS) recommendations for the care of emergent neurointerventional patients in the setting of COVID-19 have been published by Justin F. Fraser, MD, et al online in Journal of NeuroInterventional Surgery (JNIS).
News | 05.06.20
DIRECT-MT Studies Endovascular Thrombectomy With or Without Intravenous Alteplase in Acute Stroke
May 6, 2020—Investigators in the DIRECT-MT study of Chinese patients with acute ischemic stroke from large-vessel occlusion concluded that endovascular thrombectomy alone was noninferior with regard to functional outcome, within a 20% margin of confidence, compared with endovascular thrombectomy preceded by intravenous alteplase administered within 4.5 hours after symptom onset.
News | 04.29.20
Cerus Endovascular’s 021 Contour Neurovascular System Receives CE Mark Approval
April 29, 2020—Cerus Endovascular Ltd. announced that it has received European CE Mark approval for its 0.021-inch Contour neurovascular system, which is compatible with smaller commercially available 0.021-inch microcatheters for the treatment of saccular intracranial aneurysms.
News | 04.07.20
Enrollment Completed Early for TIGER Study of Rapid Medical's Tigertriever Thrombectomy Device
April 7, 2020—Rapid Medical, an Israel-based developer of next-generation neurovascular interventional devices, announced that it has completed enrollment ahead of schedule in the TIGER study, which is evaluating the performance of the company's Tigertriever thrombectomy device for the acute treatment of ischemic stroke.
News | 03.30.20
News | 03.28.20
SNIS Provides Recommendations for Emergent Neurointerventional Patients in the COVID-19 Setting
March 28, 2020—The Society of NeuroInterventional Surgery (SNIS) announced it has developed a set of care recommendations for neurointerventional physicians that cover management of stroke thrombectomy, with an emphasis on safety measures for health care providers in the context of the COVID-19 pandemic.
News | 03.17.20
Interim Study Results Presented for Artio Medical’s Endura Embolization System
March 17, 2020—Artio Medical announced that interim nonclinical study results for the company’s Endura embolization system were presented by Blaise Baxter, MD, at the ABC-WIN (Anatomy-Biology-Clinical Correlations–Working Group in Interventional Neuroradiology) seminar held January 12–17 in Val d'Isere, France.
News | 03.09.20
Transradial Access for Neurointerventions Supported by Systematic Review of the Literature
March 9, 2020—A systematic literature review of the use of transradial access (TRA) for neurointerventional cases found that the TRA approach demonstrated a relatively low rate of access site complications and crossovers.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.